163 related articles for article (PubMed ID: 38623252)
1. Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients.
Cheng B; Xu L; Zhang Y; Yang H; Liu S; Ding S; Zhao H; Sui Y; Wang C; Quan L; Liu J; Liu Y; Wang H; Zheng Z; Wu X; Guo J; Wen Z; Zhang R; Wang F; Liu H; Sun S
Heliyon; 2024 Apr; 10(7):e29299. PubMed ID: 38623252
[TBL] [Abstract][Full Text] [Related]
2. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
3. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and mutation analysis of class 1/2/3 BRAF mutation colorectal cancer.
Huang Y; Jia W; Zhao G; Zhao Y; Zhang S; Li Z; Wu G
Chin Clin Oncol; 2024 Feb; 13(1):3. PubMed ID: 38372057
[TBL] [Abstract][Full Text] [Related]
5. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
[TBL] [Abstract][Full Text] [Related]
8. A novel NGS-based microsatellite instability (MSI) status classifier with 9 loci for colorectal cancer patients.
Zheng K; Wan H; Zhang J; Shan G; Chai N; Li D; Fang N; Liu L; Zhang J; Du R; Wu Q; Li X; Zhang C
J Transl Med; 2020 May; 18(1):215. PubMed ID: 32466784
[TBL] [Abstract][Full Text] [Related]
9. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
Kim H; Kim BH; Lee D; Shin E
Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
[TBL] [Abstract][Full Text] [Related]
10. Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
Stahler A; Stintzing S; von Einem JC; Westphalen CB; Heinrich K; Krämer N; Michl M; Modest DP; von Weikersthal LF; Decker T; Kiani A; Heintges T; Kahl C; Kullmann F; Scheithauer W; Moehler M; Kaiser F; Kirchner T; Jung A; Heinemann V
Eur J Cancer; 2020 Sep; 137():250-259. PubMed ID: 32810748
[TBL] [Abstract][Full Text] [Related]
11. Molecular spectrum of
Al-Shamsi HO; Jones J; Fahmawi Y; Dahbour I; Tabash A; Abdel-Wahab R; Abousamra AO; Shaw KR; Xiao L; Hassan MM; Kipp BR; Kopetz S; Soliman AS; McWilliams RR; Wolff RA
J Gastrointest Oncol; 2016 Dec; 7(6):882-902. PubMed ID: 28078112
[TBL] [Abstract][Full Text] [Related]
12. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.
He SY; Li YC; Wang Y; Peng HL; Zhou CL; Zhang CM; Chen SL; Yin JF; Lin M
World J Gastroenterol; 2022 Jul; 28(25):2920-2936. PubMed ID: 35978873
[TBL] [Abstract][Full Text] [Related]
13. Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series.
Domingo E; Camps C; Kaisaki PJ; Parsons MJ; Mouradov D; Pentony MM; Makino S; Palmieri M; Ward RL; Hawkins NJ; Gibbs P; Askautrud H; Oukrif D; Wang H; Wood J; Tomlinson E; Bark Y; Kaur K; Johnstone EC; Palles C; Church DN; Novelli M; Danielsen HE; Sherlock J; Kerr D; Kerr R; Sieber O; Taylor JC; Tomlinson I
Lancet Gastroenterol Hepatol; 2018 Sep; 3(9):635-643. PubMed ID: 30042065
[TBL] [Abstract][Full Text] [Related]
14. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
15. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
[TBL] [Abstract][Full Text] [Related]
16. KRAS, NRAS, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania.
Brinzan CS; Aschie M; Cozaru GC; Deacu M; Dumitru E; Burlacu I; Mitroi A
Medicine (Baltimore); 2022 Oct; 101(40):e30979. PubMed ID: 36221415
[TBL] [Abstract][Full Text] [Related]
17. NGS-based oncogenic mutations analysis in advanced colorectal cancer patients improves targeted therapy prediction.
Li W; Qiu T; Guo L; Ying J; Zhou A
Pathol Res Pract; 2019 Mar; 215(3):483-489. PubMed ID: 30611619
[TBL] [Abstract][Full Text] [Related]
18. Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience.
Youssef ASE; Abdel-Fattah MA; Lotfy MM; Nassar A; Abouelhoda M; Touny AO; Hassan ZK; Mohey Eldin M; Bahnassy AA; Khaled H; Zekri ARN
Curr Issues Mol Biol; 2022 Mar; 44(3):1332-1352. PubMed ID: 35723313
[TBL] [Abstract][Full Text] [Related]
19. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
[TBL] [Abstract][Full Text] [Related]
20. Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression.
Fu Y; Ye Y; Liu X; Zhu G; Xu Y; Sun J; Wu H; Feng F; Wen Z; Jiang S; Li Y; Zhang Q
Transl Cancer Res; 2021 Jun; 10(6):2812-2821. PubMed ID: 35116591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
